SQLite Web: event_store.db

Update row sig_1eabecffb9b0 in signals

id

Primary key. TEXT

event_id

TEXT NOT NULL

watcher_id

TEXT

signal_type

TEXT NOT NULL

value

{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001965301-26-000044.txt","as_of":"2026-04-21T03:09:54.871544+00:00","canonical_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001965301-26-000044.txt","company":"Roivant Sciences Ltd.","enrichment":{"aggregator_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001965301-26-000044.txt","article_chars":2336,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_d90d783cf7319935","canonical_host":"sec.gov","canonical_is_aggregator":false,"canonical_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001965301-26-000044.txt","content_type":"text/plain","enriched_at":"2026-04-21T10:44:45.179822+00:00","extraction_method":"trafilatura","fetched_description":"","fetched_title":"","final_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001965301-26-000044.txt","html_truncated":false,"paywall_likely":false,"publisher_domain":"sec.gov","publisher_resolution":"canonical_url","requested_url":"https://www.sec.gov/Archives/edgar/data/1635088/0001965301-26-000044.txt","source_event_id":"evt_01126b24a07d","source_quality":"high","status_code":200,"version":"signal_enrichment_v2"},"form_type":"144","fp":"59ff55968680e74d","kind":"sec_filing","published_at":"20260420","publisher_domain":"sec.gov","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["2026-04-20","2026-02-13","2026-02-20","2026-04-20","2025-03-28"],"entities":[{"asset_class":"equity","name":"Roivant Sciences Ltd.","relevance":"high","symbol":"","type":"issuer"},{"asset_class":"equity","name":"Eric Venker","relevance":"high","symbol":"","type":"reporting_owner"},{"asset_class":"other","name":"National Financial Services LLC","relevance":"medium","symbol":"","type":"broker_or_agent"},{"asset_class":"other","name":"Heather Virgoe","relevance":"low","symbol":"","type":"authorized_representative"},{"asset_class":"other","name":"Rockefeller Financial LLC","relevance":"low","symbol":"","type":"address_entity"}],"event_type":"listing","information_gaps":["The signal is labeled discovery_sec_filing_delta, but no prior known state or previous filing is provided, so the exact delta vs prior state cannot be determined from the provided text.","The text shows multiple line items (including share counts and prices), but the full table structure is not explicitly labeled; only the presence of those entries is confirmed.","No explicit total shares across all line items is stated in a single consolidated figure in the provided excerpt."],"key_facts":["Filing type: Form 144 (SEC Act of 1933).","Filed as of date: 2026-04-20; accession number: 0001965301-26-000044.","Subject company/issuer: Roivant Sciences Ltd. (CIK 0001635088; SEC file number 001-40782).","Reporting owner: Eric Venker (organization name shown as Venker Eric).","Reported transaction includes: 200,000 common shares with a transaction date of 04/20/2026.","The filing states the shares will be sold pursuant to a Rule 10b5-1 trading plan adopted on 03/28/2025.","The filing includes additional entries for Eric Venker with common shares and dates in 02/13/2026, 02/20/2026, and 04/20/2026 (share counts and prices are shown in the text)."],"numeric_claims":[{"label":"shares_reported_04/20/2026","value":"200000"},{"label":"rule_10b5_1_plan_adoption_date","value":"03/28/2025"},{"label":"filing_date_as_of","value":"20260420"},{"label":"accession_number","value":"0001965301-26-000044"}],"primary_claim":"On 2026-04-20, Roivant Sciences Ltd. filed Form 144 indicating Eric Venker will sell 200,000 common shares under a Rule 10b5-1 trading plan adopted on 2025-03-28.","relevance_score":0.55,"sentiment":"neutral","source_quality":"high","summary":"Roivant Sciences Ltd. filed a Form 144 on 2026-04-20 reporting planned sales of shares by reporting owner Eric Venker. The filing states the shares will be sold under a Rule 10b5-1 trading plan adopted on 2025-03-28.","topics":["SEC Form 144","Rule 10b5-1 trading plan","insider/affiliate share sale","Roivant Sciences Ltd."]},"source":"sec_edgar","source_domain":"sec.gov","summary":"Form 144 \u00b7 Roivant Sciences Ltd. \u00b7 Filed 20260420","ticker":"ROIV","tickers":["ROIV"],"title":"ROIV filed 144","url":"https://www.sec.gov/Archives/edgar/data/1635088/0001965301-26-000044.txt"}

TEXT NOT NULL

threshold

TEXT

direction

TEXT

severity

TEXT

window

TEXT

source

TEXT NOT NULL

reason_trace

TEXT

dedupe_key

TEXT NOT NULL

throttle_s

INTEGER (default 0

created_at

TEXT NOT NULL (default strftime('%Y-%m-%dT%H:%M:%fZ','now')

Cancel